QP
VKTX icon

Quilter Plc’s Viking Therapeutics VKTX Stock Holding History

Quilter Plc’s Portfolio VKTX Stock Details VKTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-30,000
Closed -$188K – 313
2021
Q3 		$188K Hold
30,000
– – 0.01% 282
2021
Q2 		$180K Hold
30,000
– – 0.01% 305
2021
Q1 		$190K Buy
+30,000
New +$211K 0.01% 304

Other funds holding VKTX

ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PWAM
Park West Asset Management San Francisco, California $1.18B AUM 47.25% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Quilter Plc's VKTX Position: Q4 2021 in Review

Quilter Plc sold out of Viking Therapeutics (VKTX) in Q4 2021, closing a stake of 30,000 shares — an estimated $188K sold.

Quilter Plc first reported a position in VKTX in Q1 2021 and held it in 3 quarters. The position peaked at $190K in Q1 2021. 140 funds tracked by Wall St. Rank hold VKTX as of Q4 2021.

  • Quilter Plc reported no remaining Viking Therapeutics position as of Q4 2021 after selling out during the quarter.
  • Quilter Plc sold 30,000 Viking Therapeutics shares in Q4 2021, an estimated $188K.
  • Quilter Plc first reported a position in Viking Therapeutics in Q1 2021 and held it in 3 quarters.
  • Quilter Plc's Viking Therapeutics position peaked at $190K in Q1 2021.
  • 140 funds tracked by Wall St. Rank held Viking Therapeutics as of Q4 2021.

Based on Quilter Plc's 13F filing for Q4 2021, filed 14 Feb 2022.